Sun Pharma to Buy India’s Ranbaxy for $4B

Sun Pharma to Buy India’s Ranbaxy for $4B Play

April 7 (Bloomberg) –- Bloomberg’s John Dawson reports on India’s largest drug maker agreeing to purchase Ranbaxy in a $4B stock transaction. He speaks to Rishaad Salamat on Bloomberg Television’s “On The Move Asia.” (Source: Bloomberg)

blog comments powered by Disqus